Abstract

Case study of tocilizumab in the treatment of macrophage activation syndrome secondary to systemic lupus erythematosus

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call